Latest placebo Stories
NutraGenesis announces a recent study published in the peer reviewed Journal of Clinical Psychiatry, the multi-patented, GRAS-affirmed, standardized Ashwagandha root and leaf extract, Sensoril®,
CARLSBAD, Calif., June 27, 2014 /PRNewswire/ -- Essentialis announced today the dosing of the first patient in clinical study PC025, which is designed to evaluate the safety and efficacy of
Cognitive Deficit and Depression Symptoms Improve Significantly, Trial Data Shows GERMANTOWN, Md., June 25, 2014 /PRNewswire/ -- Neuralstem, Inc.
Gelesis100 2.25 g demonstrated significant weight loss in a double-blind, placebo-controlled, parallel-group 12-week study of overweight and obese subjects, including prediabetics BOSTON,
SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published
LONDON, June 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal Phase III studies - KODIAC-4 and KODIAC-5
BURLINGTON, ON, June 19, 2014 /CNW/ - Results from a Phase III 52 week study, show tiotropium (delivered via Respimat(®)*)5µg, a once-daily long-acting anticholinergic bronchodilator, is efficacious
MOMENCE, Ill., June 17, 2014 /PRNewswire/ -- FutureCeuticals, Inc.
Takeda and Lundbeck to Present Late-breaker at International College of Neuropsychopharmacology World Congress VANCOUVER, British Columbia, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical
CAMBRIDGE, England, June 16, 2014 /PRNewswire/ -- Convergence Pharmaceuticals ("Convergence" or "the
- A trick or prank.